GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (MEX:EW) » Definitions » Cyclically Adjusted Revenue per Share

Edwards Lifesciences (MEX:EW) Cyclically Adjusted Revenue per Share : MXN153.01 (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Edwards Lifesciences Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Edwards Lifesciences's adjusted revenue per share for the three months ended in Mar. 2025 was MXN49.169. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is MXN153.01 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Edwards Lifesciences's average Cyclically Adjusted Revenue Growth Rate was 8.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 10.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 13.10% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 13.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Edwards Lifesciences was 15.20% per year. The lowest was 8.60% per year. And the median was 12.80% per year.

As of today (2025-05-18), Edwards Lifesciences's current stock price is MXN1492.13. Edwards Lifesciences's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was MXN153.01. Edwards Lifesciences's Cyclically Adjusted PS Ratio of today is 9.75.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Edwards Lifesciences was 23.68. The lowest was 8.13. And the median was 13.33.


Edwards Lifesciences Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Edwards Lifesciences's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edwards Lifesciences Cyclically Adjusted Revenue per Share Chart

Edwards Lifesciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 93.67 109.70 122.28 119.48 161.14

Edwards Lifesciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 120.93 131.47 148.82 161.14 153.01

Competitive Comparison of Edwards Lifesciences's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, Edwards Lifesciences's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Edwards Lifesciences's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Edwards Lifesciences's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Edwards Lifesciences's Cyclically Adjusted PS Ratio falls into.


;
;

Edwards Lifesciences Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Edwards Lifesciences's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=49.169/134.9266*134.9266
=49.169

Current CPI (Mar. 2025) = 134.9266.

Edwards Lifesciences Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 14.670 100.684 19.659
201509 15.766 100.392 21.190
201512 17.413 99.792 23.544
201603 18.371 100.470 24.671
201606 21.540 101.688 28.581
201609 21.850 101.861 28.943
201612 24.190 101.863 32.042
201703 25.624 102.862 33.612
201706 23.515 103.349 30.700
201709 22.986 104.136 29.783
201712 27.016 104.011 35.046
201803 25.192 105.290 32.283
201806 28.884 106.317 36.657
201809 26.513 106.507 33.588
201812 30.151 105.998 38.380
201903 30.258 107.251 38.066
201906 32.817 108.070 40.973
201909 33.943 108.329 42.277
201912 34.713 108.420 43.200
202003 41.672 108.902 51.631
202006 34.420 108.767 42.698
202009 39.942 109.815 49.076
202012 36.970 109.897 45.390
202103 39.393 111.754 47.561
202106 43.484 114.631 51.183
202109 42.647 115.734 49.719
202112 43.174 117.630 49.523
202203 42.429 121.301 47.195
202206 44.104 125.017 47.600
202209 42.485 125.227 45.776
202212 13.604 125.222 14.658
202303 43.066 127.348 45.629
202306 36.392 128.729 38.144
202309 35.535 129.860 36.922
202312 35.414 129.419 36.921
202403 36.536 131.776 37.409
202406 42.015 132.554 42.767
202409 44.589 133.029 45.225
202412 48.936 133.157 49.586
202503 49.169 134.927 49.169

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Edwards Lifesciences  (MEX:EW) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Edwards Lifesciences's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1492.13/153.01
=9.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Edwards Lifesciences was 23.68. The lowest was 8.13. And the median was 13.33.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Edwards Lifesciences Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Edwards Lifesciences's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Edwards Lifesciences Business Description

Address
One Edwards Way, Irvine, CA, USA, 92614
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.